Literature DB >> 20941485

Is exogenous administration of IL-1ra (anakinra) likely to induce severe depression?

Annie Pierre Jonville-Bera, Jean-Louis Guilmot, Gilles Aspe, Elisabeth Autret-Leca, Julie Magnant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20941485     DOI： 10.1007/s00228-010-0915-1

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

1.  Crohn disease worsened by anakinra administration.

Authors:  John D Carter; Joanne Valeriano; Frank B Vasey
Journal:  J Clin Rheumatol       Date:  2003-08       Impact factor: 3.517

2.  Increased serum interleukin-1-receptor-antagonist concentrations in major depression.

Authors:  M Maes; E Vandoolaeghe; R Ranjan; E Bosmans; R Bergmans; R Desnyder
Journal:  J Affect Disord       Date:  1995-12-24       Impact factor: 4.839

3.  Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression.

Authors:  A M Myint; Y K Kim
Journal:  Med Hypotheses       Date:  2003 Nov-Dec       Impact factor: 1.538

4.  Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

Authors:  M Maes; E Bosmans; R De Jongh; G Kenis; E Vandoolaeghe; H Neels
Journal:  Cytokine       Date:  1997-11       Impact factor: 3.861

5.  Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study.

Authors:  Yuri Milaneschi; Anna Maria Corsi; Brenda W Penninx; Stefania Bandinelli; Jack M Guralnik; Luigi Ferrucci
Journal:  Biol Psychiatry       Date:  2008-12-25       Impact factor: 13.382
  5 in total
  2 in total

1.  SARS-CoV-2 Psychiatric Sequelae: A Review of Neuroendocrine Mechanisms and Therapeutic Strategies.

Authors:  Mary G Hornick; Margaret E Olson; Arun L Jadhav
Journal:  Int J Neuropsychopharmacol       Date:  2022-01-12       Impact factor: 5.176

2.  Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist.

Authors:  Boris Klementiev; Shizhong Li; Irina Korshunova; Oksana Dmytriyeva; Stanislava Pankratova; Peter S Walmod; Laura K Kjær; Mattias S Dahllöf; Morten Lundh; Dan P Christensen; Thomas Mandrup-Poulsen; Elisabeth Bock; Vladimir Berezin
Journal:  J Neuroinflammation       Date:  2014-02-03       Impact factor: 8.322
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.